CBD Modestly Reduced Some of THC's Behavioral Effects but Produced Unexpected Epigenetic Brain Changes When Given Together Long-Term
Over 15 days of combined CBD and THC in mice, CBD modestly inhibited THC's rebound hyperactivity and sensorimotor effects, but the combination produced unexpected epigenetic and molecular changes in the brain's reward pathway.
Quick Facts
What This Study Found
Researchers examined whether CBD modulates THC's effects during repeated co-administration over 15 days in mice. The behavioral results were mixed: CBD modestly inhibited THC-induced rebound locomotor hyperactivity and slightly reduced acute sensorimotor gating effects, but only at a 1:1 ratio. Increasing to 5:1 CBD:THC did not enhance these effects. CBD did not alter THC-induced anxiety or the development of tolerance.
However, the molecular findings were more surprising. The combination of CBD and THC increased histone H3 acetylation (H3K9/14ac) in the ventral tegmental area (VTA) and ΔFosB expression in the nucleus accumbens, both markers associated with neuroadaptation in the reward pathway. These changes were not seen with either compound alone, suggesting their combination produces "supradditive" (greater than the sum of parts) molecular effects.
Importantly, there was no evidence of CBD potentiating THC's behavioral effects, but the long-term molecular changes suggest the brain's reward circuitry responds differently to the combination than to either compound individually.
Key Numbers
15-day treatment period. CBD:THC ratios: 1:1 and 5:1. Modest behavioral effects at 1:1 only. Increased H3K9/14ac in VTA. Increased ΔFosB in nucleus accumbens. No CBD potentiation of THC behavior. No anxiety reduction from CBD co-administration.
How They Did This
Mice received 15 days of treatment with THC alone, CBD alone, or CBD+THC at 1:1 or 5:1 ratios. Behavioral tests included locomotor activity, sensorimotor gating, anxiety, and pharmacological tolerance. Brain tissue was analyzed for histone acetylation and ΔFosB expression in the mesolimbic dopamine pathway.
Why This Research Matters
Medical cannabis products like Sativex use specific CBD:THC ratios, and many consumers choose "balanced" products. This study suggests that while CBD may offer some acute behavioral protection against THC effects, the long-term molecular consequences of combining the two may be more complex than assumed. The epigenetic changes in reward circuitry warrant further investigation.
The Bigger Picture
The "CBD protects against THC" narrative is popular but may be oversimplified. This study shows CBD's acute behavioral modulation of THC is subtle at best, and the long-term molecular picture is more complex, with the combination producing unique epigenetic changes in reward circuits that neither compound causes alone.
What This Study Doesn't Tell Us
Mouse study that may not directly translate to humans. Only two CBD:THC ratios tested. The functional significance of the epigenetic changes (histone acetylation, ΔFosB) for behavior is not established by this study. The doses and treatment duration may not reflect typical human cannabis use patterns.
Questions This Raises
- ?Do the epigenetic changes from combined CBD+THC have functional consequences for reward sensitivity or addiction vulnerability?
- ?Would longer treatment periods amplify these molecular effects?
- ?Should medical cannabis dosing guidelines consider these unexpected molecular interactions?
Trust & Context
- Key Stat:
- CBD+THC together caused unique epigenetic changes in reward circuits that neither compound caused alone
- Evidence Grade:
- Preliminary evidence from a single animal study with novel epigenetic findings.
- Study Age:
- Published in 2017. Among the first studies to examine long-term molecular effects of CBD+THC combination.
- Original Title:
- Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway.
- Published In:
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 27(2), 132-145 (2017)
- Authors:
- Todd, Stephanie M, Zhou, Cilla(4), Clarke, David J, Chohan, Tariq W, Bahceci, Dilara, Arnold, Jonathon C
- Database ID:
- RTHC-01535
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Does CBD cancel out THC's effects?
This study found CBD only modestly reduced some of THC's behavioral effects (rebound hyperactivity, sensorimotor gating) and did not reduce THC-induced anxiety or tolerance. The common belief that CBD fully "counteracts" THC is not supported by these findings.
Is combining CBD and THC safer than THC alone?
The behavioral data suggested slight benefits, but the molecular data complicated the picture: CBD+THC together caused unique epigenetic changes in the brain's reward pathway that neither compound caused on its own. The long-term significance of these changes is unknown.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-01535APA
Todd, Stephanie M; Zhou, Cilla; Clarke, David J; Chohan, Tariq W; Bahceci, Dilara; Arnold, Jonathon C. (2017). Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 27(2), 132-145. https://doi.org/10.1016/j.euroneuro.2016.12.004
MLA
Todd, Stephanie M, et al. "Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway.." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2017. https://doi.org/10.1016/j.euroneuro.2016.12.004
RethinkTHC
RethinkTHC Research Database. "Interactions between cannabidiol and Δ9-THC following acute ..." RTHC-01535. Retrieved from https://rethinkthc.com/research/todd-2017-interactions-between-cannabidiol-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.